Data as of Dec 26
| +0.12 / +0.72%|
The 7 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +13.10% increase from the last price of 16.80.
The current consensus among 9 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.